Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 6/20 | 0.79 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.65 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.49 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6178698 | 1.00 | LMNA (0.79) | LMNATRPA1PKMHTTGAA | |
| SCHEMBL6177256 | 0.87 | LMNA (0.79) | LMNATRPA1GAAL3MBTL1CA1 | |
| SCHEMBL6180279 | 0.87 | LMNA (0.79) | LMNATRPA1HTTGAACA1 | |
| SCHEMBL6177254 | 0.87 | LMNA (0.79) | LMNATRPA1GAAL3MBTL1CA1 | |
| SCHEMBL6180284 | 0.87 | LMNA (0.79) | LMNATRPA1HTTGAACA1 | |
| SCHEMBL6178870 | 0.79 | TRPA1 (1.00) | LMNATRPA1ALDH1A1MAPTTSHR | |
| SCHEMBL6178865 | 0.79 | TRPA1 (1.00) | LMNATRPA1ALDH1A1MAPTTSHR | |
| SCHEMBL6180512 | 0.79 | LMNA (0.65) | LMNATRPA1GAAALDH1A1MAPT | |
| SCHEMBL6180337 | 0.77 | TRPA1 (0.73) | LMNATRPA1HTTGAAL3MBTL1 | |
| SCHEMBL6180330 | 0.77 | TRPA1 (0.73) | LMNATRPA1HTTGAAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1165510-B1 | 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS | HOFFMANN LA ROCHE (CH) | 2005-09-28 | — | — | EP | disclosed |
| US-6284785-B1 | HAVING ACTIVITY AS LIGANDS OF METABOTROPIC GLUTAMATE RECEPTORS | HOFFMANN- LA ROCHE INC. | 2001-09-04 | — | — | US | disclosed |